related documents
- A Patient-Risk Based Health System Intervention for Acute Heart Failure Care: The Comparison of Outcomes and Access to Care for Heart Failure (COACH) Trial Conferences
- A Randomized Controlled Trial of Continued versus Interrupted Novel Oral Anti-Coagulant at the Time of Device Surgery (BRUISE CONTROL-2) Conferences
- ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors Conferences
- Alcohol Consumption and Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis Conferences
- Alcohol Consumption and Cardiovascular Outcomes in Patients With Atrial Fibrillation; a RE-LY AF Registry Analysis Conferences
- Atrial Substrate Modification With Aggressive Blood Pressure Control to Prevent Atrial Fibrillation (SMAC AF) Conferences
- Causes of Death in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization: Insights From Voyager Pad Conferences
- Comparison of Cardiac Computerized Tomography Angiography and Transesophageal Echocardiography for Device Surveillance After Endovascular Left Atrial Appendage Closure Conferences
- Comparison of Contemporary Bleeding Risk Scores in Patients With Non-Valvular Atrial Fibrillation Treated With Dabigatran or Warfarin: Insights From the RE-LY Trial Conferences
- Costs Impact Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial Conferences
- Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AF Conferences
- Electrocardiographic Changes After Cardiac Surgery and 30-Day Mortality Conferences
- Exception to Consent in Pediatric Resuscitation Research: Exploring the Experiences of Substitute Decision Makers Conferences
- High-Sensitivity Cardiac Troponin I at Presentation in Patients With Suspected Acute Coronary Syndrome Conferences
- Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study Conferences
- Idarucizumab in Dabigatran-Treated Patients Requiring Emergency Surgery or Intervention: Updated/Final Results From the RE-VERSE AD Study Conferences
- Impact of Rivaroxaban Alone or in Combination With Aspirin versus Aspirin in Preventing Graft Occlusion in Patients With CABG Surgery COMPASS CABG Conferences
- Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Conferences
- Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes Conferences
- Improved Treatment Satisfaction Independent of Stroke and Bleeding Risk Among Patients Transitioned From a Vitamin K Antagonist to Rivaroxaban: A XANTUS-ACTS Analysis Conferences
- Interim Results of a Phase 2 Study With RBT-1 Evaluating Postoperative Course in Patients Undergoing Elective CABG/Valve Surgery on Cardiopulmonary Bypass Conferences
- Intermittent Myocardial Stretch Elicits a Reduction in Left Ventricular Diastolic Compliance and Pathologic Characteristics of Heart Failure With Preserved Ejection Fraction in Swine Conferences
- Knowledge to Action: Rationale and Design of the Patient-Centred Care Transitions in Heart Failure (PACT-HF) Pragmatic Trial Conferences
- Lower May Not Be Better: Systolic Blood Pressure and Risk of Major Adverse Limb Events in Patients With Symptomatic Peripheral Artery Disease After Revascularization: Insights From Voyager Pad Conferences
- Marked Global Variability in Cost Effectiveness of Lipid-Lowering and Combination Antihypertensive Therapies in Primary Prevention: Analyses of the HOPE-3 Trial Conferences
- Mineralocorticoid Receptor Antagonists and Atrial Fibrillation: A Systematic Review and Meta-Analysis Conferences
- Phosphorylation of Acetylcoa Carboxylase by Ampk In Platelets Controls Thromboxane Generation, Dense Granules Secretion and Thrombus Formation Conferences
- Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor in Patients With Cardiovascular Risk Factors: ASSERT II Conferences
- RISK STRATIFICATION FOR AMPUTATION IN PATIENTS WITH SYMPTOMATIC PAD AFTER LOWER EXTREMITY REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD Conferences
- Randomized Trial of Short vs Ultra Short Radial Artery Clamp Time Post Trans-radial Cardiac Catheterization Conferences
- Risk Profile and Efficacy and Safety of Rivaroxaban in Patients Undergoing Revascularization For Claudication: Insights From VOYAGER PAD Conferences
- Risk Profile and Efficacy and Safety of Rivaroxaban in Patients Undergoing Revascularization For Claudication: Insights From VOYAGER PAD Conferences
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies Conferences
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies Conferences
- Safety and Efficacy of Routine Defibrillation Testing at Time of Defibrillator Implantation: A Meta-analysis of Randomized-Controlled Trials Conferences
- Sex Differences in the Etiology and Burden of Heart Failure Across the Sociodemographic Index: Analysis of 204 Countries and Territories, 1990-2019 Conferences
- TRiCS III - An International Multicenter Randomized Trial of Transfusion Requirements in Cardiac Surgery Conferences
- Testosterone Levels and Risk for Cardiovascular Events - A Report From the ORIGIN (Outcome Reduction With an Initial Glargine Intervention) Trial Conferences
- The Effect of Blood Pressure and Cholesterol Lowering on Cognition Conferences
- The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial Conferences
- The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention -Insights From the CURRENTOASIS 7 Trial Conferences